Milestone Pharmaceuticals (MIST) announced that cardamyst nasal spray, its first commercial product, is now available through ...
CARDAMYST is now conveniently available to patients through retail pharmaciesNational sales force hired with promotional launch in mid-FebruaryExpected $25 copay cap for eligible commercially insured ...
Detailed price information for Milestone Pharmaceuticals Inc (MIST-Q) from The Globe and Mail including charting and trades.
Milestone Pharmaceuticals announced a Commercial Launch Plan investor event, indicating proactive engagement with investors and transparency about its upcoming strategies. The event will detail the ...
GAITHERSBURG, Md., Jan. 14, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that it has entered into an agreement to obtain exclusive commercial rights in the U.S. and ...
Inclusion of neffy on Express Scripts commercial formularies was effective November 22, 2024 and expands access to patients and caregivers managing Type 1 Allergic Reactions SAN DIEGO, Dec. 19, 2024 ...
Whether you’re stuffed up from allergies or are dealing with the common cold, the best nasal decongestants help reduce the ...
All bottles of three nasal rinse sprays sold over the last six years by Biomic Sciences have been recalled after FDA testing found four kinds of microbial contamination. In its recall notice, Biomic ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results